13023_2019_1202_MOESM2_ESM.xlsx (53.24 kB)
MOESM2 of Agreement between results of meta-analyses from case reports and clinical studies, regarding efficacy and safety of idursulfase therapy in patients with mucopolysaccharidosis type II (MPS-II). A new tool for evidence-based medicine in rare diseases
dataset
posted on 2019-10-22, 19:05 authored by Miguel Sampayo-Cordero, Bernat Miguel-Huguet, Almudena Pardo-Mateos, Andrea Malfettone, José Pérez-García, Antonio Llombart-Cussac, Javier Cortés, Marc Moltó-Abad, Cecilia Muñoz-Delgado, Marta Pérez-Quintana, Jordi Pérez-LópezAdditional file 2. This file includes all the references screened in the systematic review and the reason for exclusion.
